ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Clinical trial NCT04829604 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04829604
- Sponsor
- Ambrx, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-26
- Primary completion
- 2026-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.